Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jul;44(1):1–14. doi: 10.1038/bjc.1981.141

Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells.

F Stenbäck, R Peto, P Shubik
PMCID: PMC2010659  PMID: 6789853

Abstract

Delay between initiation and promotion on mouse skin was in 1949 reported by Berenblum and Shubik not to affect tumour yields, and this led to the important concept of the irreversibility of initiation and stimulated the development of multistage models. Subsequent reports have, however, suggested that delay does decrease tumour yields, and this is confirmed by the present study of 2200 mice initiated at 8, 48, or 68 weeks with 10, 30, 100, or 300 microgram of DMBA and promoted by a standard dose of TPA for 15 weeks, after various delays. However, our data suggest that the decrease in tumour yields is chiefly or wholly due to a reduction, among ageing mice, of the ability to respond to promoters, and not to any substantial loss of initiated cells, for late initiation with immediate promotion also yielded a less rapid response than early initiation with immediate promotion. Interpretation of all such studies is complicated by the few weeks that the skin needs to repair ulceration and other damage induced by the higher doses of DMBA, for if promotion with TPA begins before such repair is complete the tumour yield may be misleadingly increased.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERENBLUM I., HARAN-GHERA N., TRAININ N. An experimental analysis of the hair cycle effect in mouse skin carcinogenesis. Br J Cancer. 1958 Sep;12(3):402–413. doi: 10.1038/bjc.1958.48. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERENBLUM I., SHUBIK P. The persistence of latent tumour cells induced in the mouse's skin by a single application of 9:10-dimethyl-1:2-benzanthracene. Br J Cancer. 1949 Sep;3(3):384–386. doi: 10.1038/bjc.1949.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  4. Hieger I. Studies in carcinogenesis. Br J Cancer. 1965 Dec;19(4):761–776. doi: 10.1038/bjc.1965.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Manil L., Van Cantfort J., Lapière C. M., Gielen J. E. Significant variation in mouse-skin aryl hydrocarbon hydroxylase inducibility as a function of the hair growth cycle. Br J Cancer. 1981 Feb;43(2):210–221. doi: 10.1038/bjc.1981.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Peto R., Pike M. C. Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics. 1973 Sep;29(3):579–584. [PubMed] [Google Scholar]
  7. ROE F. J., SALAMAN M. H. A quantitative study of the power and persistence of the tumour-initiating effect of ethyl carbamate (urethane) on mouse skin. Br J Cancer. 1954 Dec;8(4):666–676. doi: 10.1038/bjc.1954.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Raick A. N. Cell proliferation and promoting action in skin carcinogenesis. Cancer Res. 1974 May;34(5):920–926. [PubMed] [Google Scholar]
  9. Roe F. J., Carter R. L., Mitchley B. C., Peto R., Hecker E. On the persistence of tumour initiation and the acceleration of tumour progression in mouse skin tumorigenesis. Int J Cancer. 1972 Mar 15;9(2):264–273. doi: 10.1002/ijc.2910090204. [DOI] [PubMed] [Google Scholar]
  10. Stenbäck F., Peto R., Shubik P. Initiation and promotion at different ages and doses in 2200 mice. II. Decrease in promotion by TPA with ageing. Br J Cancer. 1981 Jul;44(1):15–23. doi: 10.1038/bjc.1981.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stenbäck F., Peto R., Shubik P. Initiation and promotion at different ages and doses in 2200 mice. III. Linear extrapolation from high doses may underestimate low-dose tumour risks. Br J Cancer. 1981 Jul;44(1):24–34. doi: 10.1038/bjc.1981.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. TOMATIS L., TERRACINI B., SHUBIK P. Effect of a single application of croton oil in skin carcinogenesis. Proc Soc Exp Biol Med. 1962 Jan;109:18–20. doi: 10.3181/00379727-109-27089. [DOI] [PubMed] [Google Scholar]
  13. VANDUUREN B. L., ORRIS L., ARROYO E. TUMOUR-ENHANCING ACTIVITY OF THE ACTIVE PRINCIPLES OF CROTON TIGLIUM L. Nature. 1963 Dec 14;200:1115–1116. doi: 10.1038/2001115a0. [DOI] [PubMed] [Google Scholar]
  14. Van Duuren B. L., Sivak A., Katz C., Seidman I., Melchionne S. The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis on mouse skin. Cancer Res. 1975 Mar;35(3):502–505. [PubMed] [Google Scholar]
  15. Van Duuren B. L., Sivak A., Langseth L. The tumor-promoting activity of tobacco leaf extract and whole cigarette tar. Br J Cancer. 1967 Jun;21(2):460–463. doi: 10.1038/bjc.1967.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Van Duuren B. L., Smith A. C., Melchionne S. M. Effect of aging in two-stage carcinogenesis on mouse skin with phorbol myristate acetate as promoting agent. Cancer Res. 1978 Mar;38(3):865–866. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES